BPTH

Bio-Path Holdings Provides Clinical and Operational Update

06/03 07:00 am

Bio-Path Holdings Provides 2025 Clinical and Operational Update

01/10 08:00 am

Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients

12/11 08:00 am

Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

10/08 08:00 pm

Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference

09/03 07:00 am

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at European Hematology Association Congress

06/14 07:00 am

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

06/05 05:46 pm

Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting

06/03 07:00 am

Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress

05/24 07:00 am

Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting

05/23 05:00 pm

Bio-Path Holdings Reports First Quarter 2024 Financial Results

05/15 07:00 am

Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024

05/08 07:00 am

Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

04/19 12:14 pm

Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study

04/19 10:14 am

Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

04/18 01:57 pm

Dow Surges Over 100 Points; D.R. Horton Posts Upbeat Earnings

04/18 10:04 am

Bio-Path Holdings Expands Global Patent Portfolio

04/15 07:00 am

Bio-Path Holdings Provides 2024 Clinical and Operational Update

04/02 07:00 am

Bio-Path Holdings Reports Full Year 2023 Financial Results

03/08 08:00 am

Bio-Path Holdings Announces 1-for-20 Reverse Stock Split

02/21 08:00 am

Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients

01/10 08:00 am

Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia

12/14 08:00 am

Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

11/27 09:10 am

Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023

11/08 08:00 am

Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

10/18 08:18 am

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

10/17 01:42 pm

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session

10/16 01:09 pm

Why ContraFect Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket

10/16 08:47 am

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session

10/13 01:14 pm

Dow Jumps Over 200 Points; JPMorgan Earnings Top Estimates

10/13 09:48 am

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

10/13 07:35 am

Bio-Path Holdings to Present at H.C. Wainwright 25th Annual Global Investment Conference

09/08 04:01 pm

Bio-Path Holdings to Announce Second Quarter 2023 Financial Results on August 15, 2023

08/08 07:00 am

Crude Oil Rises 2.5%; Kellogg Posts Upbeat Earnings

08/03 02:43 pm

Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

08/03 12:48 pm

Nasdaq Edges Higher; ISM Services PMI Falls In July

08/03 12:02 pm

Dow Falls Over 100 Points; US Initial Jobless Claims Move Higher

08/03 09:57 am

Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering

08/03 08:22 am

Bio-Path Holdings Announces Positive Results from Interim Analysis of Phase 2 Clinical Trial of Prexigebersen in Acute Myeloid Leukemia

08/01 07:00 am

Bio-Path Holdings Announces Successful Completion of First Dose Cohort in Phase 1/1b Clinical Trial of BP1001-A in Solid Tumors

07/17 07:00 am

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

06/26 12:31 pm

Bio-Path Holdings Reports First Quarter 2023 Financial Results

05/12 07:00 am

Bio-Path Holdings to Announce First Quarter 2023 Financial Results on May 12, 2023

05/05 07:00 am

Bio-Path Holdings Reports Full Year 2022 Financial Results

03/31 07:00 am

Bio-Path Holdings to Announce Fourth Quarter and Full Year 2022 Financial Results on March 31, 2023

03/24 04:01 pm

Bio-Path Holdings Provides Clinical and Operational Update

03/16 07:00 am

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday

11/08 06:00 am

Bio-Path Holdings Announces First Patient Dosed in Phase 1/1b Study of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients

10/24 07:00 am

Bio-Path Holdings to Present at H.C. Wainwright 24th Annual Global Investment Conference

09/06 07:00 am

Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022

08/09 07:00 am